For: | Yu JW, Zhao Q, Li PX, Zhang YX, Gao BX, Xiang LB, Liu XY, Wang L, Sun YJ, Yang ZZ, Shi YJ, Chen YF, Yu MB, Zhang HK, Zhang L, Xu QH, Ren L, Li D, Lyu Y, Ren FG, Lu Q. Duodenal mucosal ablation with irreversible electroporation reduces liver lipids in rats with non-alcoholic fatty liver disease. World J Gastroenterol 2025; 31(16): 105188 [PMID: 40308802 DOI: 10.3748/wjg.v31.i16.105188] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v31/i16/105188.htm |
Number | Citing Articles |
1 |
Amedeo Lonardo, Ming-Hua Zheng. Targeting duodenum to reverse MASLD. Exploration of Digestive Diseases 2025; 4 doi: 10.37349/edd.2025.100577
|
2 |
Cornelius J Fernandez, Sweekruti Jena, Vijaya Lakshmi, Joseph M Pappachan. Duodenal mucosal ablation: An emerging therapeutic concept for metabolic dysfunction-associated fatty liver disease. World Journal of Gastroenterology 2025; 31(28): 109468 doi: 10.3748/wjg.v31.i28.109468
|